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Introduction
Patients  with  pulsatile  tinnitus  (PT)  should  be  evaluated  with
different  criteria  than  those  suffering  sensorineural  tinnitus,
as  this  feature  suggests,  in  most  cases,  a  speciﬁc  etiol-
ogy  (Table  1).  The  most  common  cause  of  vascular  PT  is
atherosclerotic  disease  due  to  endovascular  ﬂow  changes,
passing  from  a  laminar  to  turbulent  state  and  generating
the  sound  perceived  by  the  patient.1,2 The  use  of  contra-
ceptive  methods  has  become  popular,  and  the  side  effects
of  hormone  exposure  should  always  be  considered.3
The  aim  of  this  study  is  to  report  the  case  of  a  female
patient  who  had  pulsatile  tinnitus  related  to  a  progestin
(levonorgestrel)-containing  intrauterine  device.
Case report
CLP,  a  32-year-old  Caucasian  woman  born  in  São  Paulo,  for
about  1  year  had  experienced  pulsatile  tinnitus  in  the  right
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reserved.ar  that  was  synchronous  with  her  heartbeat.  The  patient
elated  the  onset  of  symptoms  to  months  after  the  birth  of
er  son.  She  denied  head  trauma,  dizziness  or  hearing  loss;
he  experienced  difﬁculty  sleeping  due  to  the  intensity  of
he  tinnitus  (score  =  8  on  a  visual  analogue  scale,  VAS),  and
eported  discreet  evening  swelling  of  her  lower  limbs.  As  to
er  personal  history,  this  patient  denied  systemic  diseases
uch  as  hypertension,  diabetes,  hyper-  or  hypothyroidism.
he  patient  had  an  intrauterine  device  (IUD)  placed  about  6
onths  previously.
On physical  examination,  the  patient  was  normotensive
nd  with  normal  bilateral  otoscopy.  She  reported  decreased
innitus  during  cervical  compression  maneuver  over  large
essels  on  the  right,  but  with  no  change  on  head  rotation.
ervical  auscultation  revealed  no  thrills  or  murmurs  with
he  stethoscope.  Laboratory  workup:  hemoglobin  14  g/dL,
ematocrit  41%,  normal  levels  for  total  cholesterol  and  its
ractions,  triglycerides  and  thyroid  hormones.  This  patient
xhibited  normal  pure  tone  and  speech  audiometry  and
mpedance  tests.
An  imaging  evaluation  (Doppler  ultrasound  of  carotid
nd  vertebrals,  tomography  of  temporal  bones,  magnetic
esonance  of  inner  ears  and  cranial  angioresonance)  was
erformed,  with  no  identiﬁed  abnormalities  (Fig.  1).
After  the  most  frequent  causes  of  vascular  PT  were
uled  out,  it  was  hypothesized  a  relationship  with
er  progestin-containing  intrauterine  device.  Our  patient
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Table  1  Causes  of  pulsatile  tinnitus.
Vascular  causes
Arterial  Atherosclerotic  disease;  aberrant
carotid  in  middle  ear;  dehiscence
of internal  carotid  in  the  middle
ear; persistent  stapedial  artery;
intrameatal  vascular  loop
Venous  Venous  hum;  dehiscent  or  high
jugular  bulb  in  middle  ear
Tumors  Paraganglioma;  arteriovenous
malformations
Muscular  causes
Myoclonus  Soft  palate;  pharyngeal  muscles;
middle  ear  muscles
Eustachian
tube
Patent  Eustachian  tube
Third  window
syndrome
Superior  semicircular  canal
dehiscence;  vestibular  aqueduct
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(syndrome;  perilymphatic  ﬁstulaeceived  instructions  regarding  the  cause  of  tinnitus,  and
as  treated  with  a  beta-blocker  (metoprolol  50  mg/day)
ith  signiﬁcant  improvement  of  symptoms.  The  patient
tarted  to  sleep  better  (score  =  3  for  tinnitus  in  VAS)  and
t
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igure  1  Magnetic  resonance  (A),  magnetic  resonance  angiography
C) and  axial  slices,  without  vascular  changes  that  could  justify  a  coOnishi  ET  et  al.
iscontinued  the  medication  after  two  months,  resulting  in
ncreased  intensity  of  tinnitus.  Because  of  the  persistence
f  considerable  discomfort,  removal  of  the  IUD  was  carried
ut,  with  complete  remission  of  tinnitus.
iscussion
evonorgestrel  is  a  progestin  (synthetic  progesterone)
idely  used  as  hormonal  contraceptive,  with  efﬁcacy  and
afety  already  deﬁned.  The  agent  can  be  administered  orally
r  as  an  intrauterine  implant.4
Progesterone  in  larger  quantities  increases  the  reabsorp-
ion  of  sodium,  chloride  and  water  in  distal  renal  tubules
ith  consequent  change  in  the  blood  crasis  and  in  its  dynam-
cs  and  endovascular  ﬂow.  A  search  with  imaging  methods
p.  ex.,  Doppler  ultrasound,  MRI  and  angio-MR)  is  the  most
ppropriate  choice.2,5 In  the  present  case,  the  absence  of
esions  that  could  justify  the  presence  of  PT  reinforced  the
ypothesis  of  hemodynamic  change,  secondary  to  the  use  of
evonorgestrel.
The  inner  ear  is  very  susceptible  to  hormonal  changes
nd  ﬂuctuations;  nevertheless,  we  do  not  believe  that  this  is
he  mechanism  of  tinnitus  generation,  since  speciﬁc  proges-
erone  receptors  have  not  been  identiﬁed  in  the  cochlea.3
he  use  of  oral  contraceptives  was  associated  with  vesti-
ular  disorders,  with  alterations  in  vestibular  examination
 (B)  and  computerized  tomography  of  temporal  bones  in  coronal
mplaint  of  pulsatile  tinnitus.
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and  tinnitus,5 but  our  search  did  not  ﬁnd  studies  with
intrauterine  devices  in  the  literature  review.
The  great  diversity  of  diagnoses  related  to  PT  requires
a  thorough  investigation;  and  this  is  time-consuming  and
demands  ﬁnancial  resources.1,6 The  American  Academy  of
Otolaryngology  (AAO-HNS)  review  recommends  investigation
in  cases  of  unilateral  tinnitus,  pulsatile  tinnitus,  focal  neu-
rological  abnormalities  (focal  neurological  symptoms),  or
asymmetric  hearing  loss.7
In  this  case,  of  those  factors  that  would  be  associ-
ated  with  the  generation  of  vascular  pulsatile  tinnitus,  we
emphasize  hypertension,  atherosclerosis,  thyroid  hormones
or  blood  crasis  changes,  and  changes  in  endovascular  ﬂow
dynamics  caused  by  ﬂuid  retention  related  to  progestin.
Considering  that  clinical  and  ancillary  (laboratory  and  imag-
ing)  tests  ruled  out  primary  causes,  and  in  view  of  an
improvement  of  symptoms  with  a  low-dose  beta-blocker,  we
suggested  discontinuation  of  the  contraceptive  agent.  With
tinnitus  improvement  after  the  removal  of  the  intrauter-
ine  device,  we  realized  that  the  progestin  was  associated
with  the  generation  of  the  problem,  even  without  having
reintroduced  the  drug  to  evaluate  its  effect.
Final considerations
The  investigation  of  PT  with  imaging  methods  should  be
clear-sighted,  in  search  of  that  injury  justifying  its  gener-
ation,  and  with  the  choice  of  a  speciﬁc  treatment.  Good
clinical  data  and  a  judicious  history  are  equally  important
to  establish  the  diagnosis.  The  side  effects  of  contraceptive
7367
edications  should  be  considered  as  possible  causes  of
ulsatile  tinnitus.
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